Oliveira Marcela B, da Silva Jessica B, Montanha Maiara C, Kimura Elza, Diniz Andrea, Bruschi Marcos L
Postgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Maringa, Parana, Brazil.
Postgraduate Program in Biosciences and Physiopathology, State University of Maringa, Parana, Brazil.
Curr Drug Deliv. 2018;15(8):1112-1122. doi: 10.2174/1567201815666180503121043.
Bladder cancer is the second type of malignant carcinoma of the urinary tract. The treatment is time-consuming and requires maintenance doses of the drug for long period of time with important side effects. Curcumin has shown evident clinical advances in the treatment of cancer. The technology of microencapsulation and the use of mucoadhesive materials can contribute to modify the delivery and improve the bioavailability of curcumin.
The aim of this study was to design and characterize mucoadhesive microparticles containing curcumin using multivariate analysis and the spray-drying technique.
A factorial design 32+1 was employed to investigate the influence of gelatin, ethylcellulose, and curcumin on size, polydispersity index, drug content and entrapment efficiency. Microparticles were also evaluated by ATR-FTIR, X-ray diffraction, antioxidant activity, in-vitro release profile, exvivo mucoadhesion performance, and in-vitro cytotoxicity.
Microparticles showed non-uniform surface, mean diameter from 2.73 µm to 4.62 µm and polydispersity index from 0.72 to 1.09, according to the different combinations of the independent factors. These independent variables also had a significant effect on the drug content. The highest values of drug trapping efficiency were obtained with the highest concentration of curcumin and polymers. Formulations displayed slow drug release and important antioxidant activity. The good mucoadhesive performance of microparticles was assessed by the falling film technique. Moreover, the formulations did not display in vitro toxicity against Artemia salina and Fibroblasts LM(TK).
The design results were useful for developing of curcumin dosage form with good physicochemical characteristics and mucoadhesive properties for the bladder administration.
膀胱癌是泌尿系统第二常见的恶性肿瘤。其治疗过程耗时,且需要长期使用维持剂量的药物,还会产生重要的副作用。姜黄素在癌症治疗方面已显示出显著的临床进展。微囊化技术和粘膜粘附材料的使用有助于改变姜黄素的给药方式并提高其生物利用度。
本研究旨在使用多变量分析和喷雾干燥技术设计并表征含姜黄素的粘膜粘附微粒。
采用3²⁺¹析因设计来研究明胶、乙基纤维素和姜黄素对粒径、多分散指数、药物含量和包封率的影响。还通过衰减全反射傅里叶变换红外光谱(ATR-FTIR)、X射线衍射、抗氧化活性、体外释放曲线、离体粘膜粘附性能和体外细胞毒性对微粒进行评估。
根据各独立因素的不同组合,微粒表面不均匀,平均粒径在2.73 µm至4.62 µm之间,多分散指数在0.72至1.09之间。这些独立变量对药物含量也有显著影响。姜黄素和聚合物浓度最高时,药物包封率达到最高值。制剂显示出药物缓释特性和重要的抗氧化活性。通过降膜技术评估了微粒良好的粘膜粘附性能。此外,制剂对卤虫和小鼠成纤维细胞LM(TK)未显示出体外毒性。
该设计结果有助于开发具有良好理化特性和粘膜粘附性能的姜黄素剂型用于膀胱给药。